Whole-genome landscape of pancreatic neuroendocrine tumours

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature

• Publication date

  2017-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature21063PMID 28199314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

  2016cited by this paper
• Genomic analyses identify molecular subtypes of pancreatic cancer

  2016cited by this paper
• Landscape of somatic mutations in 560 breast cancer whole genome sequences

  2016cited by this paper
• A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics.

  2015cited by this paper
• Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase‐mitogen‐activated protein kinase signaling pathway

  2015cited by this paper
• High-resolution 400K oligonucleotide array comparative genomic hybridization analysis of neurofibromatosis type 1-associated cutaneous neurofibromas.

  2015cited by this paper
• ClinVar: public archive of interpretations of clinically relevant variants

  2015cited by this paper
• Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trial

  2015cited by this paper
• Whole genomes redefine the mutational landscape of pancreatic cancer

  2015cited by this paper
• Whole–genome characterization of chemoresistant ovarian cancer

  2015cited by this paper
• Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.

  2014cited by this paper
• Discovery and saturation analysis of cancer genes across 21 tumor types

  2014cited by this paper
• Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.

  2014cited by this paper
• The ‘dnet’ approach promotes emerging research on cancer patient survival

  2014cited by this paper
• The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation

  2014cited by this paper
• voom: precision weights unlock linear model analysis tools for RNA-seq read counts

  2014cited by this paper
• The genomic landscape of pediatric Ewing sarcoma.

  2014cited by this paper
• Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis

  2014cited by this paper
• A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1

  2013cited by this paper
• Distinct pathways regulated by menin and by MLL1 in hematopoietic stem cells and developing B cells.

  2013cited by this paper
• Signatures of mutational processes in human cancer

  2013cited by this paper
• The Malignant Brain Tumor (MBT) Domain Protein SFMBT1 Is an Integral Histone Reader Subunit of the LSD1 Demethylase Complex for Chromatin Association and Epithelial-to-mesenchymal Transition*

  2013cited by this paper
• MEN1 Is a Melanoma Tumor Suppressor That Preserves Genomic Integrity by Stimulating Transcription of Genes That Promote Homologous Recombination-Directed DNA Repair

  2013cited by this paper
• Somatic mutation of CDKN1B in small intestine neuroendocrine tumors

  2013cited by this paper
• MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events

  2013cited by this paper
• Menin: a scaffold protein that controls gene expression and cell signaling.

  2013cited by this paper
• IntOGen-mutations identifies cancer drivers across tumor types

  2013cited by this paper
• Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway

  2012cited by this paper
• Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

  2012cited by this paper
• Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.

  2012cited by this paper
• qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles

  2012cited by this paper
• Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

  2012cited by this paper
• Malignant Gastrointestinal Neuroectodermal Tumor: Clinicopathologic, Immunohistochemical, Ultrastructural, and Molecular Analysis of 16 Cases With a Reappraisal of Clear Cell Sarcoma-like Tumors of the Gastrointestinal Tract

  2012cited by this paper
• Mutational Processes Molding the Genomes of 21 Breast Cancers

  2012cited by this paper
• GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

  2011cited by this paper
• Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development

  2011cited by this paper
• Molecular and Cellular Pathobiology The Tumor Suppressor ProteinMenin Inhibits AKT Activation by Regulating Its Cellular Localization

  2011cited by this paper
• Altered Telomeres in Tumors with ATRX and DAXX Mutations

  2011cited by this paper
• Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks

  2011cited by this paper
• A quantitative PCR method for measuring absolute telomere length

  2011cited by this paper
• DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

  2011cited by this paper
• New Epigenetic Drivers of Cancers

  2011cited by this paper
• Promiscuous partnerships in Ewing's sarcoma.

  2011cited by this paper
• WHO Classification of Tumours of the Digestive System

  2010cited by this paper
• ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

  2010cited by this paper
• MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.

  2010cited by this paper
• Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway.

  2010cited by this paper
• Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase.

  2009cited by this paper
• Expanded extracolonic tumor spectrum in MUTYH-associated polyposis.

  2009cited by this paper
• Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays

  2009cited by this paper
• EWSR1-CREB1 and EWSR1-ATF1 Fusion Genes in Angiomatoid Fibrous Histiocytoma

  2007cited by this paper
• Differentiating Ewing's sarcoma from other round blue cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues

  2007cited by this paper
• Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts

  2007cited by this paper
• Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.

  2007cited by this paper
• Role of inherited defects of MYH in the development of sporadic colorectal cancer

  2004cited by this paper
• Multiple tumor suppressor pathways negatively regulate telomerase.

  2003cited by this paper
• Mutations in CHEK2 associated with prostate cancer risk.

  2003cited by this paper
• Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors

  2002cited by this paper
• Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force field

  2002cited by this paper
• Human Glial Cell Line-derived Neurotrophic Factor Receptor α4 Is the Receptor for Persephin and Is Predominantly Expressed in Normal and Malignant Thyroid Medullary Cells*

  2001cited by this paper
• Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.

  1998cited by this paper
• Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.

  1993cited by this paper
• Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

  1992cited by this paper

• Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways

  2026cites this paper
• Expanding the clinical tumor phenotype of the EPAS1-asssociated tumor syndrome.

  2026cites this paper
• Advances in Systemic Therapy for Metastatic Pancreatic Neuroendocrine Neoplasms

  2026cites this paper
• Relative and normalized iodine concentrations derived from photon counting computed tomography and their correlation with tumor grade and Ki67 in pancreatic neuroendocrine neoplasia: A pilot study

  2026cites this paper
• Analysis of prognostic factors for advanced pancreatic neuroendocrine carcinoma: A population-based study

  2026cites this paper
• Comprehensive next generation sequencing of middle ear neuroendocrine tumors.

  2026cites this paper
• Recent Advances in the Management of Pancreatic Neuroendocrine Tumors: From Diagnosis, Treatment to Biology.

  2026cites this paper
• Concept of neuroendocrine neoplasms of all organs with a focus on grading, subtyping

  2026cites this paper
• Distinct epigenetic aging in sporadic and hereditary neuroendocrine neoplasms.

  2026cites this paper
• Transcriptomic profiling of insulinomas reveals a new "low-endocrine" subtype with low YY1 expressions.

  2026cites this paper
• Molecular alterations in high‐grade neuroendocrine tumors of the small intestine

  2025cites this paper
• CDKN2A homozygous deletions and TSC2 somatic mutations in metastatic pancreatic neuroendocrine tumors

  2025influential citation
• Overlapping Presentations and Diverse Genetic Defects Characterize Neuroendocrine Neoplasms in a Mexican Cohort

  2025cites this paper
• Expanding the differential diagnosis of bone-forming tumors: a new entity characterized by a NIPBL::BEND2 fusion.

  2025cites this paper
• Emerging Diagnostics and Therapies in Neuroendocrine Neoplasms: A Critical Review

  2025cites this paper
• Novel HSPA8-NR4A2 rearrangement in extraskeletal myxoid chondrosarcoma: a sarcoma mimicker of neuroendocrine neoplasia.

  2025cites this paper
• Gastrointestinal cancer: molecular pathogenesis and targeted therapy

  2025cites this paper
• Diagnostic significance of the checkpoint kinase 1 gene in high-grade gastroenteropancreatic neuroendocrine neoplasms

  2025cites this paper
• Circulating Tumor DNA Profiling Identifies Actionable Mutations as Prognostic Markers in Advanced Neuroendocrine Tumors

  2025influential citation
• Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Non-Functional Pancreatic Neuroendocrine Tumors Correlate with Poor Patient Prognosis.

  2025cites this paper
• Immune checkpoint inhibitors in high-grade gastroenteropancreatic neuroendocrine neoplasms.

  2025cites this paper
• Integrated proteomic analysis identifies TYMS-dependent AMPK-mTOR signaling in pancreatic neuroendocrine tumors

  2025cites this paper
• Clinicopathological and molecular characterization of astroblastoma

  2025cites this paper
• Deep proteogenomic characterization of pancreatic solid pseudopapillary neoplasm reveals unique features distinct from other pancreatic tumors

  2025cites this paper
• Recent advances and treatment strategies in liver metastasis of pancreatic neuroendocrine tumors

  2025cites this paper
• Loss of O6‐Methylguanine‐DNA Methyltransferase Protein Expression by Immunohistochemistry Is Associated With Response to Capecitabine and Temozolomide in Neuroendocrine Neoplasms

  2025cites this paper
• Patterns and variations of copy number alterations in acute myeloid leukemia: insights from the LeukAtlas database

  2025influential citation
• The chromatin guardian ATRX is a strong prognostic biomarker in melanoma

  2025cites this paper
• Optical genome mapping identifies a novel PSIP1::TBL1X fusion in metastatic pancreatic neuroendocrine tumors

  2025cites this paper
• Conserved Neuronal-like and Secretory Programs Define the Spatial Architecture of Gastroenteropancreatic Neuroendocrine Tumors

  2025cites this paper
• Advances in Drug Therapy for Pancreatic Neuroendocrine Tumor

  2025cites this paper
• Performance of Immunohistochemistry to Detect Rb/p53 Alterations in High-Grade Neuroendocrine Neoplasms: Staining Patterns and Comparison with Genetic Testing

  2025cites this paper
• Clinicopathologic, Immunohistochemical, and Molecular Analysis of Primary Ovarian Carcinoid Tumors with Correlation of Ki67 Proliferation Index with Patient Outcomes.

  2025cites this paper
• Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms?

  2025cites this paper
• Genomic and transcriptomic landscapes of metastatic neuroendocrine neoplasms from distinct primary sites and their clinical implications

  2025influential citation
• Stratification of G2 pancreatic neuroendocrine tumors using a Ten Percent Ki-67 index cut-off based on clinicopathological and molecular analyses

  2025cites this paper
• EWSR1 Rearrangements in Basaloid Neoplasms With Adnexal Differentiation

  2025cites this paper
• Recent research advances in interleukin, microRNA and neuroendocrine tumor biomarkers (Review)

  2025cites this paper
• An SRRM3-regulated neural alternative splicing program is subverted to promote tumor progression in pancreatic neuroendocrine cells.

  2025cites this paper
• FAK inhibition disrupts tumor growth, apoptosis, and transcriptional regulation in GI-NETs

  2025cites this paper
• Distinct malignant cell states and myeloid glutamate signaling associated with aggressive pancreatic neuroendocrine tumors

  2025cites this paper
• Longitudinal analysis of serum alpha-fetoprotein in stable and progressive metastatic pancreatic neuroendocrine tumours

  2025cites this paper
• Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group.

  2025cites this paper
• MEN1-Related Neuroendocrine Tumors Show c-MET Overexpression.

  2025cites this paper
• Patient-Derived Organoids from Pancreatic Neuroendocrine Tumors: A Systematic Review of PDO Take Rates, Molecular–Biological Characteristics, and Potential for Clinical Utility

  2025cites this paper
• DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasms

  2025cites this paper
• Computed tomography-guided percutaneous biopsy for assessing tumor heterogeneity in neuroendocrine tumor metastases to the liver

  2025cites this paper
• Germline Mutations in DNA Repair Genes in Patients with Pancreatic Neuroendocrine Neoplasms: Diagnostic and Therapeutic Implications

  2025influential citation
• An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors

  2025cites this paper
• Differentiating well-differentiated neuroendocrine tumors grade 3 from poorly differentiated neuroendocrine carcinomas and adenocarcinoma with neuroendocrine differentiation: a comprehensive review

  2025cites this paper
• New Developments in VHL-Associated Neuroendocrine Neoplasms

  2025cites this paper
• Management of high-grade neuroendocrine neoplasms: impact of functional imaging.

  2025cites this paper
• Imaging Update of Pancreatic Neuroendocrine Neoplasms.

  2025cites this paper
• Improving neuroendocrine tumor treatments with mathematical modeling: lessons from other endocrine cancers

  2025cites this paper
• Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasms

  2025cites this paper
• Single‐cell transcriptomics and metabolomic analysis reveal adenosine‐derived metabolites over‐representation in pseudohypoxic neuroendocrine tumours

  2025cites this paper
• Deep sequencing reveals distinct microRNA-mRNA signatures that differentiate pancreatic neuroendocrine tumor from non-diseased pancreas tissue

  2025cites this paper
• Recurrence in Patients With Lymph Node-Negative Pancreatic Neuroendocrine Tumors.

  2025cites this paper
• PANCREATIC NEUROENDOCRINE NEOPLASMS (pNENs): GENETIC AND ENVIRONMENTAL BIOMARKERS FOR RISK OF OCCURRENCE AND PROGNOSIS.

  2025cites this paper
• Lenvatinib and Everolimus synergistically inhibit neuroendocrine neoplasms by upregulating ITGB4 expression.

  2025cites this paper
• The full-length BEND2 protein is dispensable for spermatogenesis but required for setting the ovarian reserve in mice

  2025cites this paper
• Associations Between Gastroenteropancreatic Neuroendocrine Neoplasms and Inflammatory Factors: Insights From a Two‐Sample Mendelian Randomization Analysis

  2025cites this paper
• American Association of Clinical Endocrinology Consensus Statement on Management of Multiple Endocrine Neoplasia Type 1.

  2025cites this paper
• Identification of metabolite biomarkers for pancreatic neuroendocrine tumors using a metabolomic approach.

  2025cites this paper
• Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients

  2025cites this paper
• Prognosis of small pancreatic neuroendocrine neoplasms: Functionality matters.

  2025cites this paper
• Oncocytic subtype of well differentiated neuroendocrine tumor: clinicopathologic and molecular associations of a cohort diagnosed on fine needle aspiration (FNA).

  2025cites this paper
• Molecular Classification and Characterization of Noninsulinoma: Ready for Prime Time in Clinical Practice?

  2025cites this paper
• Decoding the genetic puzzle: Mutations in key driver genes of pancreatic neuroendocrine tumors.

  2025cites this paper
• Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups.

  2025cites this paper
• Current Organoid Culture Systems in Pancreatic Cancer.

  2025cites this paper
• Overview of the histopathological and immunohistochemical characteristics of neuroendocrine neoplasms

  2025influential citation
• Genetic insight into lung neuroendocrine tumors: Notch and Wnt signaling pathways as potential targets

  2025cites this paper
• Association of modifiable risk factors and telomere length with five neuroendocrine neoplasms: a bidirectional Mendelian randomization study

  2025cites this paper
• Management of Advanced Gastroenteropancreatic Neuroendocrine Tumors

  2025cites this paper
• Small extracellular vesicle-miR-183-5p mediated crosstalk between tumor cells and macrophages in high-risk pancreatic neuroendocrine tumors

  2025influential citation
• Transcriptomic profiling of pancreatic neuroendocrine tumors: dysregulation of WNT, MAPK, PI3K, neddylation pathways and potential non-invasive biomarkers

  2025cites this paper
• Multiple Intestinal Neuroendocrine Tumors: A Literature Review and Case Report

  2025cites this paper
• Whole-Exome Sequencing Reveals High Prevalence of Germline Alterations in Neuroendocrine Neoplasms.

  2025cites this paper
• Pancreatic neuroendocrine tumors and MUTYH pathogenic variants: a multinational study

  2025influential citation
• ITGA5-Expressing Tumor Cells Interact with Schwann Cells to Drive Nerve Growth Factor-Mediated Immunosuppression of NK Cells.

  2025cites this paper
• Defining Biological Borderline Resectable Non-Functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs): A Predictive Model for Preoperative Assessment of Early Recurrence Risk.

  2025cites this paper
• Functional Pancreatic Neuroendocrine Neoplasms: An Overview

  2025cites this paper
• Pancreatic neuroendocrine neoplasms: current paradigms and diagnostic challenges.

  2025cites this paper
• Single‐cell transcriptomic analysis reveals a metastasis‐associated PCSK1+ neuroendocrine subpopulation in pancreatic neuroendocrine tumors

  2025cites this paper
• Decoding Pancreatic Neuroendocrine Tumors: Molecular Profiles, Biomarkers, and Pathways to Personalized Therapy

  2025cites this paper
• World first hybrid neuroendocrine cell line sharing properties of NET G3 and dedifferentiated NEC.

  2025cites this paper
• Preoperative prediction of microvascular invasion in pancreatic neuroendocrine tumors through analysis of portal venous phase CT images

  2025cites this paper
• Epigenomic Heterogeneity of Non-Functional Pancreatic Neuroendocrine Tumors Uncovered by Single nucleus and Spatial ATAC Profiling

  2025cites this paper
• Clinical Question: How to Approach a Patient Presenting With Sweating and Flushing

  2025cites this paper
• EWSR1::BEND2 fusion sarcoma of the urinary bladder – a case report and review of literature

  2025cites this paper
• DNA damage response and its clinical implications in pediatric cancers.

  2025cites this paper
• Fenestrating Adenocarcinoma: A Novel Salivary Gland Cancer With EWSR1::BEND2 Fusion and Predilection for the Pharynx.

  2025cites this paper
• PDIA5 and ARFIP1 as Immunogenetic Biomarkers and Therapeutic Targets in Pancreatic Neuroendocrine Neoplasms: A Multi-Omics Study Integrating MR, Gene Expression Microarray, and Single-Cell Transcriptomics

  2025cites this paper
• Basic science and translational implications of current knowledge on neuroendocrine tumors

  2025influential citation
• Liquid-based cytological diagnosis of pancreatic neuroendocrine tumors using hyperspectral imaging and deep learning

  2025cites this paper
• Pathology, molecular biology, medical oncology, and radiotherapy implications of lung neuroendocrine neoplasm classification: a multidisciplinary perspective

  2025cites this paper
• Molecular Subtypes of Pancreatic Neuroendocrine Tumors Mutated in MEN1/DAXX/ATRX Explain Biological Variability

  2025influential citation
• Novel concepts of cell-of origin in neuroendocrine neoplasms

  2025cites this paper
• Clinical Relevance of ATRX/DAXX Gene Mutations and ALT in Functioning Pancreatic Neuroendocrine Tumors

  2025influential citation